Helminthic Infestations Global Clinical Trials Review, H2, 2017

2017-09-01
Price :
Published : Sep-2017
No. of Pages : 45

Helminthic Infestations Global Clinical Trials Review, H2, 2017

Summary

GlobalData’s clinical trial report, “Helminthic Infestations Global Clinical Trials Review, H2, 2017” provides an overview of Helminthic Infestations clinical trials scenario. This report provides top line data relating to the clinical trials on Helminthic Infestations. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : GlobalData
More Reports
Title Price Buy Now

Female Hypoactive Sexual Desire Disorder Global Clinical Trials Review, H2, 2017

Female Hypoactive Sexual Desire Disorder Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Female Hypoactive Sexual Desire Disorder Global Clinical Trials Review, H2, 2017" provides an overview of Female Hypoactive Sexual Desire Disorder clinical trials scenario. This report provides top line data relating to the clinical trials on Female Hypoactive Sexual Desire Disorder. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial ......
$2500

Female Sexual Dysfunction Global Clinical Trials Review, H2, 2017

Female Sexual Dysfunction Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Female Sexual Dysfunction Global Clinical Trials Review, H2, 2017" provides an overview of Female Sexual Dysfunction clinical trials scenario. This report provides top line data relating to the clinical trials on Female Sexual Dysfunction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary databas......
$2500

Bacterial Vaginosis Global Clinical Trials Review, H2, 2017

Bacterial Vaginosis Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Bacterial Vaginosis Global Clinical Trials Review, H2, 2017" provides an overview of Bacterial Vaginosis clinical trials scenario. This report provides top line data relating to the clinical trials on Bacterial Vaginosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinic......
$2500

Postmenopausal Vaginal Atrophy Global Clinical Trials Review, H2, 2017

Postmenopausal Vaginal Atrophy Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Postmenopausal Vaginal Atrophy Global Clinical Trials Review, H2, 2017" provides an overview of Postmenopausal Vaginal Atrophy clinical trials scenario. This report provides top line data relating to the clinical trials on Postmenopausal Vaginal Atrophy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's......
$2500

Hormone Deficiency Disorders Global Clinical Trials Review, H2, 2017

Hormone Deficiency Disorders Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hormone Deficiency Disorders Global Clinical Trials Review, H2, 2017" provides an overview of Hormone Deficiency Disorders clinical trials scenario. This report provides top line data relating to the clinical trials on Hormone Deficiency Disorders. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprie......
$2500

Nocturia Global Clinical Trials Review, H2, 2017

Nocturia Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Nocturia Global Clinical Trials Review, H2, 2017" provides an overview of Nocturia clinical trials scenario. This report provides top line data relating to the clinical trials on Nocturia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are coll......
$2500

Bladder Cancer Global Clinical Trials Review, H2, 2017

Bladder Cancer Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Bladder Cancer Global Clinical Trials Review, H2, 2017" provides an overview of Bladder Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Bladder Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. ......
$2500

Growth Hormone Deficiency Global Clinical Trials Review, H2, 2017

Growth Hormone Deficiency Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Growth Hormone Deficiency Global Clinical Trials Review, H2, 2017" provides an overview of Growth Hormone Deficiency clinical trials scenario. This report provides top line data relating to the clinical trials on Growth Hormone Deficiency. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary databas......
$2500

OraSure Technologies Inc (OSUR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary OraSure Technologies Inc (OraSure) is a manufacturer and distributor of oral fluid specimen collection devices, diagnostic products and other medical devices. Its product portfolio encompasses infectious disease tests for the detection of antibodies for the HIV and Hepatitis C virus; and antigens for influenza type A and type B. OraSure also sells immunoassay tests and reagents for insurance risk assessment, substance-abuse testing and forensic toxicology applications; and products for the cryosurgical removal of warts and several other benign skin lesions. The company distributes its products to various hospitals, clinics, community-based organizations and other public health organizations, distributors, clinical laboratories, and commercial and industrial entities. The company s......
$250

Rite Aid Corp (RAD) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Rite Aid Corp (Rite Aid) is retail drugstore chain. The company sells prescription drugs and a wide range of other merchandise such as, over-the-counter (OTC) medications, personal care items, health and beauty aids, cosmetics, household items, beverages, convenience foods, greeting cards, seasonal merchanise, photo processing and others. Rite Aid services portfolio include pharmacy-related solutions including fully integrated mail, specialty and compounding pharmacy services. The company also has a technology which helps its customer to fill or refill their prescription through internet under website www.riteaid.com. It operates through subsidiaries and retail drugstores in the US. Rite Aid is headquartered in Camp Hill, Pennsylvania, the US. Rite Aid Corp (RAD) - Pharmaceutical......
$250